# US 2004/0024012 A1 · Racemization and enantiomer separation of clopidogrel

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0024012 A1
- Document ID: US20040024012A1
- Status: Published application
- Kind: A1
- Application number: 10/392,601
- Filed: 2003-03-19
- Published: 2004-02-05
- Earliest claimed: 2002-08-02
- Assignees: Teva Pharmaceutical Industries Ltd.
- Inventors: Merli Valeriano; Paola Daverio; Stefano Bianchi
- Web page: https://patentgrep.com/patent/US20040024012A1

## CPC

- C07D 513/04: Ortho-condensed systems
- A61K 31/4743: condensed with ring systems having sulfur as a ring hetero atom
- Y02P 20/582: Recycling of unreacted starting or intermediate materials
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Processes for separation of enantiomers of clopidogrel, and converting one enantiomer of clopidogrel to another enantiomer of clopidogrel are provided. The enantiomers are separated by crystallizing the (S) enantiomer as camphor sulfonate salt from a hydrocarbon, or a mixture of a hydrocarbon and a co-solvent, preferably DMF:toluene. The (R) enantiomer is then racemized and recycled by reaction with a catalytic amount of a base, preferably with t-butoxide.

## Claims

### Claim 1

A process for preparing (S) clopidogrel free base or a pharmaceutically acceptable salt thereof comprising the steps of:
a) reacting a mixture of (R) and (S) clopidogrel free base with levorotatory camphor sulfonic acid in a mixture of a C5 to a C12 hydrocarbon and a suitable co-solvent to precipitate (S) clopidogrel camphor sulfonate; and
b) converting (S) clopidogrel camphor sulfonate to clopidogrel free base or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

The process of claim 1, wherein the salt is a bisulfate salt.

### Claim 3 (depends on 1)

The process of claim 1, wherein the mixture contains from about 3% to about 20% (vol/vol) of the co-solvent.

### Claim 4 (depends on 3)

The process of claim 3, wherein the mixture contains from about 5% to about 10% of the co-solvent.

### Claim 5 (depends on 1)

The process of claim 1, wherein the co-solvent is selected from the group consisting of DMF, butanol and acetone.

### Claim 6 (depends on 1)

The process of claim 1, wherein the hydrocarbon is an aromatic hydrocarbon.

### Claim 7 (depends on 6)

The process of claim 6, wherein the aromatic hydrocarbon is selected from the group consisting of xylene, benzene, toluene and chlorobenzene.

### Claim 8 (depends on 7)

The process of claim 7, where the hydrocarbon is toluene.

### Claim 9 (depends on 1)

The process of claim 1, comprising a preliminary step of reacting a mixture of clopidogrel (R) and (S) bisulfate with a base.

### Claim 10

A process for racemizing (R) clopidogrel comprising reacting (R) clopidogrel with a catalytic amount of a base in a solvent to convert a portion of the (R) clopidogrel to (S) clopidogrel.

### Claim 11 (depends on 10)

The process of claim 10, wherein the catalytic amount is less than about 0.15 moles relative to clopidogrel.

### Claim 12 (depends on 10)

The process of claim 10, further comprising a step of crystallizing a pharmaceutically acceptable salt or a camphor sulfonate salt of the (S) clopidogrel.

### Claim 13 (depends on 12)

The process of claim 12, wherein the salt is a bisulfate salt.

### Claim 14 (depends on 10)

The process of claim 10, wherein the base is selected from the group consisting of sodium t-butoxide, potassium t-butoxide, diusopropylamide, sodium hydride, potassium hydride, sodium methoxide and potassium methoxide.

### Claim 15 (depends on 10)

The process of claim 10, wherein the solvent is a C5 to a C12 hydrocarbon.

### Claim 16 (depends on 15)

The process of claim 15, wherein the hydrocarbon is an aromatic hydrocarbon.

### Claim 17 (depends on 16)

The process of claim 16, wherein the aromatic hydrocarbon is selected from the group consisting of xylene, benzene, toluene and chlorobenzene.

### Claim 18 (depends on 17)

The process of claim 17, where the hydrocarbon is toluene.

### Claim 19 (depends on 10)

The process of claim 10, wherein the racemizing is carried out at a temperature of less than about 20° C.

### Claim 20 (depends on 19)

The process of claim 19, wherein the temperature is about 0° C.
